A robust and efficient protein biomarker development pipeline helps scientists overcome common challenges associated with ...

Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

A new study has shown that specific blood biomarkers could predict the onset of dementia, up to ten years before an actual ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Clinical trials often place a significant burden on participants ... Others include Pfizer using smartwatches and Novartis ...

Dementia affects millions of people worldwide, causing a serious impact on the economy and the healthcare system. Alzheimer’s ...

In recent years, scientists have worked hard to find better ways to detect dementia, including Alzheimer's disease, long ...

Beam Therapeutics Inc. (NASDAQ:BEAM) on Saturday presented additional data from the Phase 1/2 clinical trial of BEAM-302 in ...

This biomarker may also help to address the need for more-sensitive markers of cognitive change in therapeutic clinical trials of drugs for the treatment of Alzheimer's disease, the authors suggest.

Trial achieved key objectives for safety, tolerability, pharmacokinetics and pharmacodynamicsClinical data from this trial, ...